Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Medical Device Experts

Council Members in this Study Group: 316

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Richard Tarplin

Principal
Tarplin Strategies, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Richard Tarplin is the founder of Tarplin Strategies in Washington, DC, where he provides strategic advice and lobbying services to clients in the financial services and health care sectors. He served for almost 20 years in the US House of Representatives and US Senate and as a senior PresidentialExecutive...

Hany Salama, Vice President, Commercial Operations, NEOSTRATA COMPANY, INC.Hany Salama

Vice President, Commercial Operations
NEOSTRATA COMPANY, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Hany Salama, ME, MBA, CPM, is the Vice President, Commercial Operations at The NeoStrata Company. He has global responsibilities for commercial planning, supply chain, and manufacturing operations for all clinical and marketed products. Mr. Salama is also responsible for all new commercial productlaunches...

2 recent news post(s)
Louis Rocco

System Director of Purchasing
HALLMARK HEALTH SYSTEM, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Louis Rocco is the System Director of Purchasing at Hallmark Health System, in Massachusetts. He has over 25 years of experience in purchasing and has negotiation, analytical, reporting and communication skills in inventory, distribution, purchasing, mailroom, reimbursement and accounts payable background....

1 recent news post(s)
Stephen Bent, Partner, FOLEY & LARDNER LLPStephen Bent

Partner
FOLEY & LARDNER LLP
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Stephen A. Bent is Partner and former co-leader of the Life Sciences Industry Team at Foley & Lardner in Washington, DC. He is also a member of the Biotechnology & Pharmaceutical Practice Group and the Health Care and Nanotechnology Industry Teams. Mr. Bent specializes on the legal issues associated...

Michael McNeely

Principal
Law Offices of Michael D. McNeely
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael McNeely is in private practice in Washington, DC, where he provides antitrust counseling and representation. Mr. McNeely consults on the antitrust and antitrust agency aspects of mergers, generic drug approvals, telecommunications, patents, standard setting, and other topics. He also represents...

Eric Gruff, PhD MBA, Principal, E4 ConsultingEric Gruff, PhD MBA

Principal
E4 Consulting
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Eric Gruff, PhD, MBA, BS, is Founder of E4 Consulting, which specializes in pharmaceutical development, regulatory affairs, and project and portfolio management. Dr. Gruff has over 17 years of experience in the pharmaceutical and biotech sector, including leadership roles at Pfizer, Agouron Pharmaceuticals,...

11 recent news post(s)
Ken Powell, President, Genesis Business Development, LLCKen Powell

President
Genesis Business Development, LLC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Ken Powell is the President of Genesis Business Development, a healthcare consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of intellectual property, new businesses, and products in the clinical diagnostics and medical device market segments. He has knowledge...

189 recent news post(s)
B. Michael Silber, PHD, Chief of Drug Discovery R&D and Professor, UNIVERSITY OF CALIFORNIA, SAN FRANCISCOB. Michael Silber, PHD

Chief of Drug Discovery R&D and Professor
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Michael Silber, PhD, is Professor of Neurology, Bioengineering and Therapeutic Sciences, and Chief of Drug Discovery R & D, at the Institute for Neurodegenerative Diseases, UCSF School of Medicine. He has 25 years of experience as a senior leader in Pharma and Biotech R & D, in all major diseases.Dr....

View all Leading Experts in this Study Group

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

What's Next for Sequenom?

November 7, 2009

Ken Powell, President, Genesis Business Development, LLC

So Where Does Sequenom’s Prenatal Play Currently Stand? | www.genomeweb.com

Those following the Sequenom saga continue their seemingly endless attempts to decipher a clear direction for the company.  Amid data mishandling, executive terminations and a stunning $300 million dollar lawsuit, there could be options for the company to revive and survive.

FDA Publishes H1N1 Diagnostic Test Guidance

November 5, 2009

Ken Powell, President, Genesis Business Development, LLC

FDA Publishes Guidance Document for H1N1 Dx | www.genomeweb.com

The FDA published document designed to help diagnostic test manufactures develop H1N1 tests and data that would accompany a FDA application to market them.  This follows on the recent issuance of CDC guidelines for H1N1 tests.

Genomic Health Posts a 41% Q3 Revenue Increase

November 5, 2009

Ken Powell, President, Genesis Business Development, LLC

Genomic Health Posts 41 Percent Revenue Increase for Q3 | www.genomeweb.com

Genomic Health (NASDAQ: GHDX) posted Q3 revenues that were 41% greater than Q3 08.  Virtually all of the revenue out performance was due to sales of the company's Oncotype Dx molecular diagnostic test for breast cancer used in developing a therapeutic strategy and assessing risk of recurrence.

Court Denies Lawsuit Dismissal Motion by Myriad Genetics and Others

November 4, 2009

Ken Powell, President, Genesis Business Development, LLC

Court Denies Motion to Dismiss BRCA Patent Suit Against Myriad, Others | www.genomeweb.com

The US District Court for the Southern District of New York denied a motion to dismiss the lawsuit brought against Myriad Genetics, the US Patent and Trademark Office and the University of Utah Research Foundation by the Association for Molecular Pathology, the American Civil Liberties Union and Public...

Liquid-Based Cytology Found Not Superior to Conventional PAP

November 3, 2009

Ken Powell, President, Genesis Business Development, LLC

Alternative to Pap Test Does Not Appear to Be Better for Detecting Cervical Cancer | www.medcompare.com

A recent 90,000 patient, randomized Dutch study published in the Journal of American Medicine's October 28 issue found that liquid-based cytology is not superior to conventional Pap methods in sensitivity and specificity for cervical cancer detection.  There are two leading US companies that provide...

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Medical Device Manufacturer
  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Consultancy, Healthcare-Focused
  • Medical Device Consultancy
  • Consultancy, Pharma-Focused
  • Individual/Small Consultancy
  • Academic Institution*
  • Law Firm (general practice/large)
  • Strategic Management

Members in this Study Group often have these job titles:

  • President
  • Director
  • Chief Executive Officer
  • Owner
  • Principal
  • Physician - Attending Physician
  • Partner
  • Consultant

Related Study Groups

Study Group Name No. Members
Generic Drug Economic Experts 767
Orthopedic Device Purchasers (US) 97
Economic Experts on Medical Devices (US) 28
FDA Medical Device Regulations Experts: Legal, Economic, and Regulatory Affairs 52
Biotechnology Patent Experts: Lawyers (US) 99
Medical Tourism Experts 358
Council Members in the U.S. who are Familiar with Regulations Pertaining to Andrx Corporation's Form 483 18

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Medical Device Experts Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

GLG Webcast: Cash Flow Manipulation- July 28, 2009 at 10:30 AM EDT/7:30 AM PDT

July 28, 2009

GLG Webcast: Growth Opportunities for Healthcare Technology Companies

April 17, 2009

GLG Webcast: Cash Flow Manipulations - July 30, 2008 at 2:00 PM EST

July 30, 2008

GLGi: Cash Flow Manipulations

July 25, 2007

View the webcast

Download the presentation